查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1513221

2024 年基層醫療POC 診斷全球市場報告

Primary Care POC Diagnostics Global Market Report 2024
出版日期: | 出版商: The Business Research Company | 英文 175 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

基層醫療POC 診斷市場規模預計在未來幾年將強勁成長。預計到 2028 年將以 7.8% 的複合年成長率成長至 221.9 億美元。預測期內的預期成長是由感染疾病爆發的出現、非傳染性疾病中 POC 診斷的使用增加、居家醫療環境的採用增加、精準醫療計劃的進步、醫療基礎設施投資的增加以及疾病負擔所推動的。這被認為是由於多種因素造成的，包括患有癌症的人數增加以及人們對早期疾病檢測重要性的認知增強。預測期內預計的主要趨勢包括人工智慧（AI）和機器學習演算法的整合、分子診斷技術的進步、POC診斷設備的小型化和便攜性的提高、智慧型裝置的整合以及POC診斷的使用。復用和麵板測試。

預計感染疾病的增加將在短期內推動基層醫療POC 診斷市場的擴張。感染疾病是由細菌、病毒、真菌和寄生蟲等病原微生物引起的，透過直接或間接接觸受污染的表面、空氣、水或昆蟲等媒介傳播。導致傳播的因素包括惡劣的環境條件、都市化、抗菌素抗藥性和疫苗接種不足。基層醫療POC 診斷透過在各種醫療機構中實現早期發現、及時治療和有效的疾病管理，在應對這些感染疾病的成長方面發揮著重要作用。例如，2023年10月，健康安全局的報告顯示，英國的愛滋病毒診斷人數將增加22%，從2021年的3,118人增加到2022年的3,805人。此外，2023年11月，世界衛生組織（WHO）報告稱，2022年全球結核病病例數約為1,060萬人，不同族群的感染人數達數百萬人。因此，感染疾病的激增正在推動基層醫療POC 診斷市場的發展。

基層醫療POC 診斷市場的領導者正在專注於先進的技術解決方案，例如攜帶式照護現場RT-PCR 系統，以最佳化市場收益。這些系統專為傳統實驗室以外的即時逆轉錄聚合酵素鏈鎖反應(RT-PCR) 測試而設計，具有移動性和緊湊性。例如，Genes2Me Pvt. Ltd 於 2022 年 10 月推出了 Rapi-Q Point of Care RT PCR 解決方案。 Rapi-Q 系統可攜式，適用於醫院、血庫、診所、實驗室和機場等各種環境。它具有高靈敏度、高精度、高效能，相容於50多種疾病檢測套件，可冷凍乾燥、常溫保存。

目錄

第1章執行摘要

第2章 市場特點

第3章 市場趨勢與策略

第4章宏觀經濟情景

  • 高通膨對市場的影響
  • 烏克蘭與俄羅斯戰爭對市場的影響
  • COVID-19 對市場的影響

第5章世界市場規模與成長

  • 全球基層醫療POC 診斷市場：促進因素和限制因素
    • 市場促進因素
    • 市場限制因素
  • 全球基層醫療POC 診斷市場表現：規模與成長，2018-2023 年
  • 全球基層醫療POC 診斷市場預測：規模與成長，2023-2028 年，2033F

第6章 市場細分

  • 全球基層醫療POC 診斷市場：按產品分類的績效和預測，2018-2023、2023-2028F、2033F
  • 血糖監測
  • 心臟代謝測試產品
  • 傳染病檢查產品
  • 血液凝固檢驗產品
  • 懷孕和生育測試產品
  • 腫瘤或癌症標記檢測產品
  • 膽固醇檢測產品
  • 血液檢測產品
  • 濫用藥物 (DOA) 檢測產品
  • 其他產品
  • 全球基層醫療POC 診斷市場：按處方箋的實際情況和預測，2018-2023、2023-2028F、2033F
  • 根據處方箋
  • 非處方藥 (OTC) 測試
  • 全球基層醫療POC 診斷市場：按最終用途分類的實際情況和預測，2018-2023、2023-2028F、2033F
  • 醫院
  • 診斷中心
  • 研究室
  • 居家照護環境
  • 其他用途

第 7 章 區域/國家分析

  • 全球基層醫療POC 診斷市場：按地區分類的表現和預測，2018-2023、2023-2028F、2033F
  • 全球基層醫療POC 診斷市場：按國家/地區分類的績效和預測，2018-2023、2023-2028F、2033F

第8章亞太市場

第9章 中國市場

第10章 印度市場

第11章 日本市場

第12章 澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章 西歐市場

第16章英國市場

第17章 德國市場

第18章 法國市場

第19章 義大利市場

第20章 西班牙市場

第21章 東歐市場

第22章 俄羅斯市場

第23章 北美市場

第24章美國市場

第25章加拿大市場

第26章 南美洲市場

第27章 巴西市場

第28章 中東市場

第29章 非洲市場

第30章 競爭格局及公司概況

  • 基層醫療POC診斷市場：競爭格局
  • 基層醫療POC 診斷市場：公司簡介
    • Hoffmann-La Roche Ltd
    • Abbott Laboratories
    • Siemens Healthineers AG
    • Becton, Dickinson And Company
    • bioMerieux SA

第31章 其他大型創新企業

  • Quidel Corporation
  • Sysmex Corporation
  • Bio-Rad Laboratories Inc.
  • Nova Biomedical Corporation
  • Randox Laboratories Ltd
  • Ortho Clinical Diagnostics
  • Nipro Corporation
  • OraSure Technologies
  • Meridian Bioscience Inc
  • DiaSorin SpA
  • Sekisui Diagnostics LLC
  • EKF Diagnostics Holdings plc
  • Trinity Biotech plc
  • Fujirebio Diagnostics Inc.
  • Immunodiagnostic Systems Holdings PLC

第32章競爭基準化分析

第 33 章. 競爭對手儀表板

第34章 重大併購

第35章前瞻性與潛力分析

第36章附錄

簡介目錄
Product Code: r18208

A point-of-care (POC) diagnostic in primary care entails conducting medical tests or evaluations conveniently and swiftly within a primary care environment, such as a doctor's office or clinic, without the need for specialized equipment or extensive laboratory processing. These diagnostics aim to deliver prompt results, enabling healthcare providers to make timely decisions regarding patient care during the initial consultation.

Primary care POC diagnostics encompass a range of products, including glucose monitoring, cardiometabolic testing products, infectious disease testing products, coagulation testing products, pregnancy and fertility testing products, tumor or cancer marker testing products, cholesterol testing products, hematology testing products, drug-of-abuse (DOA) testing products, among others. Glucose monitoring involves measuring blood glucose levels to manage diabetes and is available in different types such as prescription-based and over-the-counter (OTC) testing. These are utilized across various settings, including hospitals, diagnostic centers, research laboratories, home-care settings, and others.

The primary care POC diagnostics market research report is one of a series of new reports from The Business Research Company that provides primary care POC diagnostics market statistics, including primary care POC diagnostics industry global market size, regional shares, competitors with a primary care POC diagnostics market share, detailed primary care POC diagnostics market segments, market trends and opportunities, and any further data you may need to thrive in the primary care POC diagnostics industry. This primary care POC diagnostics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The primary care POC diagnostics market size has grown strongly in recent years. It will grow from $15.32 billion in 2023 to $16.46 billion in 2024 at a compound annual growth rate (CAGR) of 7.5%. The growth observed in the historical period can be ascribed to several factors, including the rising prevalence of chronic diseases, a shift towards personalized medicine, increased healthcare spending, the implementation of supportive regulatory frameworks, streamlined approval processes, and a heightened focus on early disease detection and prevention strategies.

The primary care POC diagnostics market size is expected to see strong growth in the next few years. It will grow to $22.19 billion in 2028 at a compound annual growth rate (CAGR) of 7.8%. the anticipated growth in the forecast period can be attributed to various factors such as the emergence of infectious disease outbreaks, the expanding use of POC diagnostics in non-communicable diseases, greater adoption in home healthcare settings, advancements in precision medicine initiatives, augmented investments in healthcare infrastructure, escalating disease burden, and heightened awareness regarding the significance of early disease detection. Key trends expected in the forecast period include the integration of artificial intelligence (AI) and machine learning algorithms, advancements in molecular diagnostics technologies, the miniaturization and enhanced portability of POC diagnostic devices, the integration of smart devices, and the utilization of multiplexing and panel testing in POC diagnostics.

The anticipated increase in infectious diseases is poised to drive the expansion of the primary care POC diagnostics market in the foreseeable future. Infectious diseases, caused by pathogenic microorganisms such as bacteria, viruses, fungi, or parasites, spread through direct or indirect contact with contaminated surfaces, air, water, or vectors such as insects. Factors contributing to their prevalence include poor environmental conditions, urbanization, antimicrobial resistance, and insufficient vaccination coverage. Primary care POC diagnostics play a crucial role in addressing this rise in infectious diseases by enabling early detection, timely treatment, and effective disease control across various healthcare settings. For example, in October 2023, a report from the UK Health Security Agency revealed a 22% increase in HIV diagnoses in England from 3,118 in 2021 to 3,805 in 2022. Additionally, in November 2023, the World Health Organization reported approximately 10.6 million cases of tuberculosis globally in 2022, affecting millions across different demographics. Thus, the surge in infectious diseases is propelling the primary care POC diagnostics market forward.

Leading companies in the primary care POC diagnostics market are concentrating on advanced technological solutions, such as portable point-of-care RT-PCR systems, to optimize their market revenue. These systems, designed for real-time reverse transcription polymerase chain reaction (RT-PCR) tests outside traditional laboratories, offer mobility and compactness. For instance, Genes2Me Pvt. Ltd. introduced the Rapi-Q Point of Care RT PCR solution in October 2022, featuring an eight-well block design with four fluorescent channels, claimed to deliver rapid results in under 45 minutes. Portable and lightweight, the Rapi-Q system is suitable for various settings such as hospitals, blood banks, health clinics, research laboratories, and airports. It boasts high sensitivity, accuracy, and performance in disease detection, compatible with over 50 lyophilized, room-temperature disease detection kits.

In February 2021, Thermo Fisher Scientific Inc., a US-based biotechnology firm, acquired Mesa Biotech Inc. for about $450 million, bolstering its molecular diagnostics capabilities, particularly in POC testing, and enhancing its portfolio of infectious disease diagnostic solutions. Mesa Biotech Inc., a US-based molecular diagnostic company, specializes in primary care point-of-care tests and platforms.

Major companies operating in the primary care POC diagnostics market are Hoffmann-La Roche Ltd, Abbott Laboratories, Siemens Healthineers AG, Becton, Dickinson And Company, bioMerieux SA, Quidel Corporation, Sysmex Corporation, Bio-Rad Laboratories Inc., Nova Biomedical Corporation, Randox Laboratories Ltd, Ortho Clinical Diagnostics, Nipro Corporation, OraSure Technologies, Meridian Bioscience Inc, DiaSorin SpA, Sekisui Diagnostics LLC, EKF Diagnostics Holdings plc, Trinity Biotech plc, Fujirebio Diagnostics Inc., Immunodiagnostic Systems Holdings PLC, Quotient Limited, AccuBioTech Co. Ltd., bioMedomics Inc.

North America was the largest region in the primary care POC diagnostics market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the primary care POC diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the primary care POC diagnostics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The primary care POC diagnostics market consists of sales of respiratory pathogen testing products, thyroid function testing products, electrolyte testing products, and liver function testing products. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Primary Care POC Diagnostics Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on primary care POC diagnostics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for primary care POC diagnostics? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The primary care POC diagnostics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of COVID-19 on supply chains and consumption patterns.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Product: Glucose Monitoring; Cardiometabolic Testing Products; Infectious Disease Testing Products; Coagulation Testing Products; Pregnancy And Fertility Testing Products; Tumor Or Cancer Marker Testing Products; Cholesterol Testing Products; Hematology Testing Products; Drug-Of-Abuse (DOA) Testing Products; Other Products
  • 2) By Prescription: Prescription Based; Over-The-Counter (OTC) Testing
  • 3) By End-Use: Hospitals; Diagnostic Centers; Research Laboratories; Home-Care Settings; Other End-Uses
  • Companies Mentioned: Hoffmann-La Roche Ltd; Abbott Laboratories; Siemens Healthineers AG; Becton, Dickinson And Company; bioMerieux SA
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Primary Care POC Diagnostics Market Characteristics

3. Primary Care POC Diagnostics Market Trends And Strategies

4. Primary Care POC Diagnostics Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Primary Care POC Diagnostics Market Size and Growth

  • 5.1. Global Primary Care POC Diagnostics Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Primary Care POC Diagnostics Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Primary Care POC Diagnostics Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Primary Care POC Diagnostics Market Segmentation

  • 6.1. Global Primary Care POC Diagnostics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Glucose Monitoring
  • Cardiometabolic Testing Products
  • Infectious Disease Testing Products
  • Coagulation Testing Products
  • Pregnancy And Fertility Testing Products
  • Tumor Or Cancer Marker Testing Products
  • Cholesterol Testing Products
  • Hematology Testing Products
  • Drug-Of-Abuse (DOA) Testing Products
  • Other Products
  • 6.2. Global Primary Care POC Diagnostics Market, Segmentation By Prescription, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Prescription Based
  • Over-The-Counter (OTC) Testing
  • 6.3. Global Primary Care POC Diagnostics Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Hospitals
  • Diagnostic Centers
  • Research Laboratories
  • Home-Care Settings
  • Other End-Uses

7. Primary Care POC Diagnostics Market Regional And Country Analysis

  • 7.1. Global Primary Care POC Diagnostics Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Primary Care POC Diagnostics Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Primary Care POC Diagnostics Market

  • 8.1. Asia-Pacific Primary Care POC Diagnostics Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Primary Care POC Diagnostics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Primary Care POC Diagnostics Market, Segmentation By Prescription, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Primary Care POC Diagnostics Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Primary Care POC Diagnostics Market

  • 9.1. China Primary Care POC Diagnostics Market Overview
  • 9.2. China Primary Care POC Diagnostics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Primary Care POC Diagnostics Market, Segmentation By Prescription, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Primary Care POC Diagnostics Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Primary Care POC Diagnostics Market

  • 10.1. India Primary Care POC Diagnostics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Primary Care POC Diagnostics Market, Segmentation By Prescription, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Primary Care POC Diagnostics Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Primary Care POC Diagnostics Market

  • 11.1. Japan Primary Care POC Diagnostics Market Overview
  • 11.2. Japan Primary Care POC Diagnostics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Primary Care POC Diagnostics Market, Segmentation By Prescription, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Primary Care POC Diagnostics Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Primary Care POC Diagnostics Market

  • 12.1. Australia Primary Care POC Diagnostics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Primary Care POC Diagnostics Market, Segmentation By Prescription, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Primary Care POC Diagnostics Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Primary Care POC Diagnostics Market

  • 13.1. Indonesia Primary Care POC Diagnostics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Primary Care POC Diagnostics Market, Segmentation By Prescription, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Primary Care POC Diagnostics Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Primary Care POC Diagnostics Market

  • 14.1. South Korea Primary Care POC Diagnostics Market Overview
  • 14.2. South Korea Primary Care POC Diagnostics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Primary Care POC Diagnostics Market, Segmentation By Prescription, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Primary Care POC Diagnostics Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Primary Care POC Diagnostics Market

  • 15.1. Western Europe Primary Care POC Diagnostics Market Overview
  • 15.2. Western Europe Primary Care POC Diagnostics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Primary Care POC Diagnostics Market, Segmentation By Prescription, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Primary Care POC Diagnostics Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Primary Care POC Diagnostics Market

  • 16.1. UK Primary Care POC Diagnostics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Primary Care POC Diagnostics Market, Segmentation By Prescription, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Primary Care POC Diagnostics Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Primary Care POC Diagnostics Market

  • 17.1. Germany Primary Care POC Diagnostics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Primary Care POC Diagnostics Market, Segmentation By Prescription, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Primary Care POC Diagnostics Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Primary Care POC Diagnostics Market

  • 18.1. France Primary Care POC Diagnostics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Primary Care POC Diagnostics Market, Segmentation By Prescription, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Primary Care POC Diagnostics Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Primary Care POC Diagnostics Market

  • 19.1. Italy Primary Care POC Diagnostics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Primary Care POC Diagnostics Market, Segmentation By Prescription, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Primary Care POC Diagnostics Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Primary Care POC Diagnostics Market

  • 20.1. Spain Primary Care POC Diagnostics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Primary Care POC Diagnostics Market, Segmentation By Prescription, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Primary Care POC Diagnostics Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Primary Care POC Diagnostics Market

  • 21.1. Eastern Europe Primary Care POC Diagnostics Market Overview
  • 21.2. Eastern Europe Primary Care POC Diagnostics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Primary Care POC Diagnostics Market, Segmentation By Prescription, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Primary Care POC Diagnostics Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Primary Care POC Diagnostics Market

  • 22.1. Russia Primary Care POC Diagnostics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Primary Care POC Diagnostics Market, Segmentation By Prescription, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Primary Care POC Diagnostics Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Primary Care POC Diagnostics Market

  • 23.1. North America Primary Care POC Diagnostics Market Overview
  • 23.2. North America Primary Care POC Diagnostics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Primary Care POC Diagnostics Market, Segmentation By Prescription, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Primary Care POC Diagnostics Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Primary Care POC Diagnostics Market

  • 24.1. USA Primary Care POC Diagnostics Market Overview
  • 24.2. USA Primary Care POC Diagnostics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Primary Care POC Diagnostics Market, Segmentation By Prescription, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Primary Care POC Diagnostics Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Primary Care POC Diagnostics Market

  • 25.1. Canada Primary Care POC Diagnostics Market Overview
  • 25.2. Canada Primary Care POC Diagnostics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Primary Care POC Diagnostics Market, Segmentation By Prescription, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Primary Care POC Diagnostics Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Primary Care POC Diagnostics Market

  • 26.1. South America Primary Care POC Diagnostics Market Overview
  • 26.2. South America Primary Care POC Diagnostics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Primary Care POC Diagnostics Market, Segmentation By Prescription, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Primary Care POC Diagnostics Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Primary Care POC Diagnostics Market

  • 27.1. Brazil Primary Care POC Diagnostics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Primary Care POC Diagnostics Market, Segmentation By Prescription, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Primary Care POC Diagnostics Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Primary Care POC Diagnostics Market

  • 28.1. Middle East Primary Care POC Diagnostics Market Overview
  • 28.2. Middle East Primary Care POC Diagnostics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Primary Care POC Diagnostics Market, Segmentation By Prescription, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Primary Care POC Diagnostics Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Primary Care POC Diagnostics Market

  • 29.1. Africa Primary Care POC Diagnostics Market Overview
  • 29.2. Africa Primary Care POC Diagnostics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Primary Care POC Diagnostics Market, Segmentation By Prescription, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Primary Care POC Diagnostics Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Primary Care POC Diagnostics Market Competitive Landscape And Company Profiles

  • 30.1. Primary Care POC Diagnostics Market Competitive Landscape
  • 30.2. Primary Care POC Diagnostics Market Company Profiles
    • 30.2.1. Hoffmann-La Roche Ltd
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Abbott Laboratories
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Siemens Healthineers AG
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Becton, Dickinson And Company
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. bioMerieux SA
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Primary Care POC Diagnostics Market Other Major And Innovative Companies

  • 31.1. Quidel Corporation
  • 31.2. Sysmex Corporation
  • 31.3. Bio-Rad Laboratories Inc.
  • 31.4. Nova Biomedical Corporation
  • 31.5. Randox Laboratories Ltd
  • 31.6. Ortho Clinical Diagnostics
  • 31.7. Nipro Corporation
  • 31.8. OraSure Technologies
  • 31.9. Meridian Bioscience Inc
  • 31.10. DiaSorin SpA
  • 31.11. Sekisui Diagnostics LLC
  • 31.12. EKF Diagnostics Holdings plc
  • 31.13. Trinity Biotech plc
  • 31.14. Fujirebio Diagnostics Inc.
  • 31.15. Immunodiagnostic Systems Holdings PLC

32. Global Primary Care POC Diagnostics Market Competitive Benchmarking

33. Global Primary Care POC Diagnostics Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Primary Care POC Diagnostics Market

35. Primary Care POC Diagnostics Market Future Outlook and Potential Analysis

  • 35.1 Primary Care POC Diagnostics Market In 2028 - Countries Offering Most New Opportunities
  • 35.2 Primary Care POC Diagnostics Market In 2028 - Segments Offering Most New Opportunities
  • 35.3 Primary Care POC Diagnostics Market In 2028 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer